title: Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
authors.affiliation: Department of Tumour Biology, Norwegian Radium Hospital, Oslo, Norway.
authors.forename: P D
authors.initials: PD
authors.lastname: Rye
authors.forename: N V
authors.initials: NV
authors.lastname: Bovin
authors.forename: E
authors.initials: E
authors.lastname: Vlasova
authors.forename: H K
authors.initials: HK
authors.lastname: Høifødt
authors.forename: B
authors.initials: B
authors.lastname: Kierulf
authors.forename: G E
authors.initials: GE
authors.lastname: Trones
authors.forename: O
authors.initials: O
authors.lastname: Fodstad
mesh_terms: D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000276:immunology; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D001826:Body Fluids / Q000166:cytology; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; C033398:galactosyl-1,3-N-acetylglucosamine; D000117:Acetylglucosamine